Substance Abuse Treatment, Prevention, and Policy最新文献

{"title":"Perspectives on harm reduction kit implementation in heterogeneous outpatient clinics.","authors":"Raagini Jawa, Margaret Shang, Austen Markus, Megan Hamm, José Luiggi-Hernández, Flor de Abril Cameron, Gary McMurtrie, Olivia Studnicki, Mary Hawk, Devon Check, Jessica Merlin, Jane Liebschutz","doi":"10.1186/s13011-026-00746-1","DOIUrl":"10.1186/s13011-026-00746-1","url":null,"abstract":"<p><strong>Background: </strong>The evolving U.S. drug market has fueled a public health crisis with rising drug use-associated morbidity and mortality, revealing a mismatch between current abstinence-based addiction care and the needs of people who use drugs (PWUD) to access evidence-based harm reduction services (HRS). Co-locating HRS into outpatient clinics could reduce mortality and improve clinical outcomes. We investigated barriers and facilitators of HRS implementation through kit distribution at three heterogenous outpatient addiction clinics using pre- and post-implementation focus groups.</p><p><strong>Methods: </strong>Using a qualitative description approach, we conducted 1-hour virtual focus groups and individual interviews with clinic staff and providers both pre- and post-implementation of kit distribution. Interview guides were based on the Consolidated Framework for Implementation Research to assess anticipated and actual implementation barriers and facilitators. Interviews were analyzed using thematic analysis.</p><p><strong>Results: </strong>Five providers and six staff participated in pre-implementation data collection. Dominant themes pre-implementation included participant enthusiasm for HRS integration and anticipated barriers of personal knowledge and external stigma against PWUD. Six providers and five staff participated post-implementation. Participants reported successful kit implementation with few actual barriers, though external stigma at the individual, health system, and community levels, along with issues related to patient use and interactions with child protective services, law enforcement, and pharmacies, occasionally disrupted the process. The lack of sustainable funding for supplies and labor emerged as a primary concern for long-term sustainability, with clinics actively seeking alternative funding sources.</p><p><strong>Conclusions: </strong>Implementation of HRS in outpatient addiction clinics was well-received by providers and staff and supported by pre-implementation trainings, site champions, and favorable implementation environments. Further efforts are needed to reduce stigma in the greater community and achieve sustainable funding for HRS.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13602537/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148382876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tobacco marketing and youth perceptions: connections between industry tactics and beliefs about harm and addiction among those under 21.","authors":"Suzanne Frisbee, Meghan B Moran, Maryam Ibrahim, Lauren Czaplicki, Ryan D Kennedy","doi":"10.1186/s13011-026-00744-3","DOIUrl":"10.1186/s13011-026-00744-3","url":null,"abstract":"<p><strong>Background: </strong>Tobacco marketing shapes consumer perceptions, particularly among young people. Despite regulatory restrictions, subtle tactics may continue to mislead youth and young adults. This study examines how specific features in cigarette and e-cigarette ads affect perceived harm and addictiveness among 18-20-year-olds.</p><p><strong>Methods: </strong>We recruited 1,708 U.S. participants aged 18-20 across two survey waves (2022-2023). Participants viewed randomized cigarette and e-cigarette ads and rated perceived harm and addictiveness. Ads (n = 221) were coded for youth-relevant features. Mixed-effects logistic regression assessed associations between ad features and perceptions, adjusting for demographics, tobacco use, brand familiarity, and wave.</p><p><strong>Results: </strong>For e-cigarette ads, flavors and gift promotions were associated with a lower likelihood of inaccurate harm perceptions, while sweepstakes, social media engagement, and socialization themes were linked to a higher likelihood of inaccurate harm perceptions. In cigarette ads, use cues and pleasure claims were linked to a lower likelihood of inaccurate harm perceptions, whereas gift promotions were linked to a higher likelihood of misperceptions. Regarding addiction, price promotions and use cues in e-cigarette ads were associated with a lower likelihood of inaccurate addiction perceptions, while sweepstakes, social media engagement, and socialization themes were linked to a higher likelihood of inaccurate addiction perceptions. For cigarette ads, only use cues predicted a lower likelihood of inaccurate addiction perceptions.</p><p><strong>Conclusion: </strong>Advertising features can influence young adults' misperceptions of nicotine and tobacco product risks. Specifically, sweepstakes, social media engagement, and youth-oriented socialization themes may obscure harm and addictiveness, especially for e-cigarettes. Findings support comprehensive regulation to address misleading marketing.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13599246/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148353572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Staff perceptions of care navigators in medication for opioid use disorder treatment settings.","authors":"Michael Goetz, Shaquita Andrews-Higgins, Olivia A Davis, Sandra Back-Haddix, Laura Fanucchi, Michelle R Lofwall, Sharon L Walsh, Hannah K Knudsen","doi":"10.1186/s13011-026-00743-4","DOIUrl":"10.1186/s13011-026-00743-4","url":null,"abstract":"<p><strong>Background: </strong>Care navigators are increasingly incorporated into medication for opioid use disorder (MOUD) treatment programs to address barriers to care and support patient engagement and retention. Prior research has largely focused on patient outcomes or program effectiveness, with limited attention to how frontline staff experience the integration of care navigators into routine treatment workflows. This study aimed to examine staff perceptions of care navigator roles and identify organizational and policy-relevant factors influencing their implementation.</p><p><strong>Methods: </strong>We conducted a qualitative study of staff perceptions of care navigators embedded in medication for opioid use disorder treatment centers participating in the HEALing Communities Study in Kentucky, USA. Semi-structured interviews were conducted with clinical and administrative staff working in participating treatment centers. Interviews explored experiences with care navigator integration, perceived impacts on patient engagement and team functioning, and implementation challenges. Data were analyzed using thematic analysis guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework and the Practical, Robust Implementation and Sustainability Model.</p><p><strong>Results: </strong>Staff described care navigators as filling critical service gaps by helping patients address practical challenges that commonly disrupt treatment engagement, including transportation barriers, housing instability, and navigating health and social services. These efforts were viewed as supporting sustained engagement in treatment with medication for opioid use disorder. Participants also reported improved team morale and reduced burnout following care navigator integration. However, staff identified persistent implementation challenges, including unclear role boundaries, scheduling constraints, and misalignment between organizational cultures. Clear differentiation between care navigators, targeted case managers, and peer support specialists was consistently identified as necessary to support effective collaboration.</p><p><strong>Conclusions: </strong>Findings suggest that care navigators may enhance engagement and workforce capacity in medication for opioid use disorder treatment settings, particularly when focused on addressing practical barriers to care. At the same time, variability in role definition and organizational fit limited effectiveness in some settings. These results highlight the importance of clear role delineation, stable funding, and implementation planning when integrating non-clinical navigation roles. Future research should incorporate patient perspectives and examine how policy and organizational contexts shape implementation and outcomes.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov Identifier: NCT04111939 (registered March 26, 2019).</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13599137/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148340301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating the effectiveness of substance use disorder treatment centers: a systematic review of international standards and outcomes.","authors":"Maryam Jafar Sameri, Majid Alizadeh, Ehsan Moradi-Joo, Nazila Azizi, Sedighe Sadat Tabatabaei Far","doi":"10.1186/s13011-026-00742-5","DOIUrl":"10.1186/s13011-026-00742-5","url":null,"abstract":"<p><strong>Background: </strong>Substance Use Disorder represents a complex global public health challenge, yet the effectiveness of treatment centers remains debated due to lack of consensus on standardized international indicators and heterogeneity of treatment modalities. This systematic review aimed to identify and synthesize key international indicators for measuring treatment success, compare effectiveness of different modalities, and assess impact on social reintegration.</p><p><strong>Methods: </strong>Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 and Population, Intervention, Comparison, Outcome frameworks, we conducted systematic searches of PubMed, Scopus, Web of Science, and Cochrane Library. Two reviewers independently screened 4,234 records, extracted data from 28 included studies, and assessed quality using Cochrane Risk of Bias 2 and Newcastle-Ottawa Scale. Heterogeneity was quantified using I-squared and tau-squared statistics.</p><p><strong>Results: </strong>Core indicators emerged in three domains: physiological (abstinence, daily functioning), psychological (reduced anxiety/depression, craving reduction), and social (employment, family relations). Medication-Assisted Treatment with methadone and buprenorphine demonstrated consistent effectiveness in reducing substance use and preventing relapse. Psychosocial interventions, particularly Cognitive Behavioral Therapy and Mindfulness-Based Relapse Prevention, significantly enhanced quality of life. Integrated models combining pharmacological and psychosocial approaches outperformed single-modality treatments. However, 78.6% of studies originated from four high-income countries, and only 17.9% reported outcomes beyond 12 months.</p><p><strong>Conclusions: </strong>Effective Substance Use Disorder treatment requires integrated models with standardized, multidimensional outcome indicators. Future research must prioritize long-term outcomes and address the substantial evidence gap in low- and middle-income countries.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13599203/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148340351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Addiction across substance use, gambling, and screen: a scoping review of coping strategies adopted by concerned significant others.","authors":"Mélissa Côté, Kim Hardy, Nadine Blanchette-Martin, Catherine Gatineau, Joël Tremblay","doi":"10.1186/s13011-026-00739-0","DOIUrl":"10.1186/s13011-026-00739-0","url":null,"abstract":"<p><strong>Background: </strong>A loved one's addiction to substance use (alcohol or drugs), gambling, or screen use (e.g. gaming, social media) has significant impact on the quality of life of concerned significant others (CSOs), affecting various aspects of their daily lives. As a result, CSOs implement a range of coping strategies to deal with their loved one's addiction and to try to preserve their personal and family well-being. Several studies have focused on the strategies used by CSOs, but none have provided a comprehensive overview of CSO's experiences of coping across substance use, gambling, or screen-related addiction contexts.</p><p><strong>Methods: </strong>A scoping review was conducted to provide a comprehensive overview of the coping strategies used by CSOs of adults whose loved ones experience substance use, gambling, or screen-related addiction. It also sought to extend the previous mapping of coping strategies among CSOs of individuals with gambling problems developed by Côté et al. (2018), by broadening its scope to include substance use and screen-related addictions. To do so, a systematic search was conducted across six databases: PsycINFO, Medline, Psychology and Behavioral Sciences Collection, SocIndex, Cinahl Complete, and Health and Psychosocial Instruments.</p><p><strong>Results: </strong>Among the 64 included studies, most focused on CSOs of individuals with substance use (64%) or gambling (26%), with fewer addressing co-occurring substance use and gambling (6%) and screen-related addiction (3%). Findings indicate that CSOs rely on a broad range of coping strategies aimed at either influencing the loved one's addiction-related behaviours or enhancing personal, couple, or family well-being, alongside emerging strategies not previously captured in existing frameworks. Despite some nuances, the results reveal a trend toward uniformity in coping strategies used by CSOs in substance use and gambling contexts. Evidence on coping strategies used by CSOs in screen-related addiction remains more limited, and comparability with substance use and gambling contexts is less established.</p><p><strong>Conclusions: </strong>CSOs demonstrate active engagement in managing the impacts of addiction through coping strategies that address both the recovery process of their loved ones and the preservation of family and relational well-being, highlighting their central role in the broader addiction context.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13528034/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148240413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring chronic pain and other clinical characteristics in drug treatment court participants.","authors":"Abigail Helm, Paige M Shaffer, Michael Andre, Eleni Kachadoorian, Sheila Casey, David Smelson","doi":"10.1186/s13011-026-00740-7","DOIUrl":"10.1186/s13011-026-00740-7","url":null,"abstract":"<p><strong>Background: </strong>Three out of four participants in Drug Treatment Courts (DTCs) present with co-occurring substance use disorders and mental health disorders (COD). Among individuals with COD outside criminal-legal settings, 71% report chronic pain. However, chronic pain has not been examined in the context of DTC participation. This secondary analysis compared intake treatment needs of DTC participants with COD, stratified by presence or absence of chronic pain history.</p><p><strong>Methods: </strong>Participants with COD from five DTCs were compared: 61 with chronic pain history (36%) and 109 without (64%). Chronic pain history was defined based on self-reported lifetime chronic pain and/or receipt of prescriptions for chronic pain management. Bivariate analyses compared pain, mental health, alcohol and illicit substance use, criminal-legal, and quality of life factors.</p><p><strong>Results: </strong>Participants with chronic pain history reported greater pain severity and pain-related interference with enjoyment and daily activities. A higher proportion of participants with chronic pain history (66%) reported non-medical prescription opioid use compared to those without chronic pain history (16%). They also reported more illicit use of oxycodone (0.05 vs. 0), more opioid overdoses (0.12 vs. 0), and fewer nights in jail (23.50 vs. 54.16). No significant differences emerged in mental health or quality of life.</p><p><strong>Conclusions: </strong>This work is the first to compare treatment needs of DTC participants with and without chronic pain history, and the sample presented with a high prevalence of chronic pain history. Therefore, DTC programs should assess for chronic pain among participants to incorporate pain management and support participants more effectively.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13483668/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148227718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Beyond the Bud: new cannabis products and modes of consumption in Ontario, Canada's legal hybrid market.","authors":"Chelsea Noël, Shawn Dookie, Deborah M Scharf","doi":"10.1186/s13011-026-00735-4","DOIUrl":"10.1186/s13011-026-00735-4","url":null,"abstract":"<p><strong>Background: </strong>Canada is home to a very active commercial legal cannabis market, offering insight into the opportunities and challenges posed by rapid cannabis commercialization under a hybrid regulatory model. This environmental scan provides a descriptive snapshot of available cannabis products, modes of consumption, and their advertised product potencies.</p><p><strong>Methods: </strong>Researchers extracted cannabis product type, mode(s) of consumption, and drug (THC, CBD) potency information from the online inventories of ten large Ontario, Canada cannabis retailers. Products and modes were categorized according to Canadian Cannabis Survey (CCS) categories where applicable.</p><p><strong>Results: </strong>Ontario retailers sell cannabis products including dried flower, hash/hashish, oils, vape pens, concentrates, edibles, beverages and topicals. Drug potencies varied within and across product types and were reported in non-standardized units. Modes of consumption included inhalation (smoking/vaping/dabbing of a range of flower and concentrate products), oral ingestion (eating, drinking), mucosal absorption (sublingual, vaginal) and topical, transdermal applications. We identified new products, terms, and features (e.g. multimodal products), not described in resources informed by the CCS.</p><p><strong>Conclusions: </strong>Ontario's hybrid cannabis retail environment demonstrates substantial product and labeling diversity. These findings underscore the importance of adaptable surveillance frameworks capable of capturing evolving products, modes, and potency reporting practices. This scan offers a structured, replicable approach to monitoring cannabis product and mode trends in a rapidly evolving legal market context and may inform regulatory and public health discussions internationally.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13422286/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148056987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Substance use and treatment utilization patterns of working-age American men who were not in employment, education, or training (NEET) during the COVID-19 pandemic.","authors":"Wayne Kepner, Keith Humphreys","doi":"10.1186/s13011-026-00733-6","DOIUrl":"10.1186/s13011-026-00733-6","url":null,"abstract":"<p><strong>Background: </strong>A growing population of working-aged men are not in employment, education, or training (NEET). The COVID-19 pandemic has been associated with changes in rates of substance use disorders (SUDs) and treatment seeking in the general population, but COVID-era substance use patterns among NEET men are unknown.</p><p><strong>Methods: </strong>We estimated the prevalence and correlates of NEET status among working-aged (18-64) men using data from the 2022 National Survey on Drug Use and Health, a nationally representative survey of non-institutionalized individuals in the United States. We developed logistic regression models to examine associations between NEET status and substance use behaviors and treatment engagement, adjusted for sociodemographic factors.</p><p><strong>Results: </strong>An estimated 11.1% of working-aged men were NEET in 2022 representing 10.6 million individuals. Compared to non-NEET men, NEET men were significantly overrepresented among older age groups, lower income brackets, unmarried individuals, those with lower educational attainment, and Non-Hispanic Black men. After adjusting for sociodemographic factors, NEET status was significantly associated with higher odds of prescription tranquilizer/sedative use disorder (aOR = 3.54, 95% CI: 1.97-6.37), methamphetamine use disorder (aOR = 3.10, 95% CI: 1.82-5.28), and prescription pain‑reliever use disorder (aOR = 2.88, 95% CI: 1.82-4.53), while being inversely associated with alcohol use disorder (aOR = 0.68, 95% CI: 0.54-0.85).</p><p><strong>Conclusion: </strong>More than 1 in 10 working-aged men were NEET in 2022. Adjusted models showed higher odds of past-year SUDs but lower odds of alcohol use disorder. Targeted interventions should include age-appropriate, culturally tailored, and substance-specific treatment programs to improve public health.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13422309/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148006751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A community-based systematic review of economic evaluations of overdose prevention sites for people who use drugs: a study protocol.","authors":"Ehsan Jozaghi","doi":"10.1186/s13011-025-00668-4","DOIUrl":"10.1186/s13011-025-00668-4","url":null,"abstract":"<p><strong>Background: </strong>Over 100 overdose prevention sites (OPS) operate in various jurisdictions, including Australia, Canada, the United States, and several European countries. However, despite the increasing prevalence of people who use illegal drugs, including those who inject drugs, no such facility currently operates in Africa, Asia, the Middle East, the Caribbean, or Central and South America. Except for Canada and a few sites in the US, no sanctioned facility currently operates in Mexico.</p><p><strong>Methods: </strong>This systematic review will identify peer-reviewed studies, reports, and theses that evaluate the cost and benefits of OPS, relying on five electronic databases (ECONLIT, Google Scholar, Medline, PubMed, and Web of Science). A search strategy based on the PRESS approach will guide the initial search for articles. Based on the PRISMA, community researchers will screen titles and abstracts using the specified inclusion criteria in EndNote X20, and the results will be uploaded into Covidence. Community reviewers using Covidence will examine the complete text, including the title and abstract. All articles reported through the initial search will be further screened based on Cheers and Drummond criteria to identify weaknesses in the research while extracting additional information and data related to costs, benefits, programs, or services. The final data analysis will include the range of cumulative benefits, costs, and ratios associated with operating OPS.</p><p><strong>Discussion: </strong>This review has the potential to provide evidence-based knowledge through a community-based research approach on the cost savings of public health interventions implemented through harm reduction philosophy for underserved populations.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":"21 1","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13188599/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147975663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Alcohol and mental health care integration in traumatically injured patients with elevated BAC: a retrospective chart review.","authors":"Nicholas R Schumann, Madeline R Marks, Devi Jayan, Jorian Greenwood, Sydney C Timmer-Murillo, Timothy J Geier, Claire M Bird, Andrew T Schramm, Sacha A McBain","doi":"10.1186/s13011-026-00736-3","DOIUrl":"10.1186/s13011-026-00736-3","url":null,"abstract":"<p><strong>Background: </strong>Alcohol is a well-documented risk factor for motor vehicle collisions (MVCs) and may also heighten post-trauma psychological symptoms. Given the frequent co-occurrence of MVC injury, alcohol use, and post-injury mental health sequelae, coordinated post-injury care is critical to support long-term psychological and physical recovery. The American College of Surgeons Committee on Trauma requires screening for and intervention on risky alcohol use and, more recently, to conduct mental health risk screening and referral. However, little is known about how established alcohol screening and intervention workflows interface with mental health services in routine practice.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of adults (≥ 18 years) with traumatic injuries at a Level I Trauma Center in the U.S. Midwest from 2017 to 2022. Data were pulled from the trauma registry and electronic medical record. A chart review was completed on a subset of patients who were legally intoxicated at the time of admission to assess engagement with services using a structured abstraction template.</p><p><strong>Results: </strong>From January 2017 to December 2022, 198 patients were admitted after MVC. Of the 154 patients tested for blood alcohol concentration (BAC), 78% were legally intoxicated (≥ 0.08 g/dL). 58% screened at high risk for PTSD or depression on the Injured Trauma Survivor Screen (ITSS). Of the patients legally intoxicated, 25 received at least one visit from trauma psychology. Alcohol use was discussed in 60% of these encounters, primarily regarding frequency and quantity. Eleven patients (45.8%) had alcohol use explicitly addressed and were provided resources by social work.</p><p><strong>Conclusions: </strong>These findings suggest that alcohol use, despite its significance in this high-risk population, was minimally addressed across specialty services.</p>","PeriodicalId":22041,"journal":{"name":"Substance Abuse Treatment, Prevention, and Policy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13422042/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147983344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}